MLN2704 / Takeda  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
MLN2704 / Takeda
NCT00052000: A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Completed
1
29
US
MLN2704 (DM1 conjugated monoclonal antibody MLN591)
Millennium Pharmaceuticals, Inc.
Prostate Cancer
 
 
NCT00058409: MLN2704 in Treating Patients With Progressive Metastatic Prostate Cancer

Completed
1
US
MLN2704
Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Prostate Cancer
 
 

Download Options